Taysha Gene Therapies, Inc. TSHA Fair Value Adjustment Of Warrants
Fair Value Adjustment Of Warrants at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s fair value adjustment of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s fair value adjustment of warrants?
- Taysha Gene Therapies, Inc. (TSHA) reported fair value adjustment of warrants of $736K in Q4 2025.
- How has Taysha Gene Therapies, Inc.'s fair value adjustment of warrants changed year-over-year?
- Taysha Gene Therapies, Inc.'s fair value adjustment of warrants increased by 986.7% year-over-year, from -$83K to $736K.
- What does fair value adjustment of warrants mean?
- This reflects the periodic non-cash gain or loss resulting from the revaluation of outstanding warrant liabilities to their current fair market value. Changes in this metric are driven by fluctuations in the company's stock price and volatility. It is a non-operating item that impacts net income without affecting immediate cash flow.